Final results from the landmark NURTURE study highlight the profound impact of early treatment with 12 mg SPINRAZA in clinically presymptomatic SMA with 92% of
Personalis, Inc., a leader in advanced genomics for precision oncology, announced the presentation of new clinical results from the PREDICT DNA and SCANDARE studies highlighting
MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60% of patients testing positive one month after surgery had tumor
25 Years of Trust Powers GHX’s Mission to Strengthen Healthcare Supply Chain Resilience Global Healthcare Exchange , the industry’s leading platform for smarter, more resilient supply chains,
Novel Device Shown to Dramatically Improve Scope Stability and Control for Gastroenterologists of All Skill Levels Neptune Medical, a leader in medical device innovation, announced
Fuel up with free Health Tech Insights
